Sensyne Health plc
("Sensyne" or the "Company")
Change in Registered Office
Oxford, U.K. - 28 March 2022: Sensyne Health plc (LSE:SENS) ("Sensyne" or the "Company") announces that the Company's registered office address has changed to John Eccles House,
Robert Robinson Avenue, Oxford Science Park, Oxford, OX4 4GP with immediate effect.
All other details remain the same including the Company's website (www.sensynehealth.com), and telephone number (+44 (0) 330 058 1845).
This announcement has been made in accordance with Rule 17 of the AIM Rules for Companies.
-ENDS-
Notes for editors:
About Sensyne Health: https://www.sensynehealth.com/
Sensyne Health plc (LSE: SENS) is a clinical artificial intelligence company operating a unique business model - a for-profit plc making a positive social impact, sharing the financial returns it makes with health systems. The company applies clinical AI in the healthcare and life science industries. In healthcare, Sensyne delivers remote patient monitoring and real-time decision-making systems for healthcare organisations and their patients. In life sciences, Sensyne analyses large complex anonymized data sets to help life sciences companies accelerate the development of new medicines.
Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L).
Contact details:
| Sensyne Health | |
| |
| Lord (Paul) Drayson PhD FREng, Chief Executive Officer Dr Richard Pye, Chief Financial Officer | +44 (0) 330 058 1845 |
| |
| Peel Hunt LLP (Nominated Adviser and Joint Broker) | + 44 (0) 20 7418 8900 |
| |
| Dr Christopher Golden James Steel
| |
| |
| Liberum (Joint Broker) | | ||
| Phil Walker William Hall | + 44 (0) 20 3100 2000 | ||
| Consilium Strategic Communications | | ||
| Mary-Jane Elliott Jessica Hodgson CSCSensynehealth@consilium-comms.com | +44 (0) 7780 600290 | ||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
